Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Mallinckrodt
McKinsey
Colorcon
McKesson

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMBIEN CR

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Ambien Cr

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00042146 Behavioral and Pharmacological Treatment for Insomnia Completed National Institute of Mental Health (NIMH) Phase 4 2001-12-01 This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (AmbienĀ®), for chronic insomnia.
NCT00042146 Behavioral and Pharmacological Treatment for Insomnia Completed Laval University Phase 4 2001-12-01 This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (AmbienĀ®), for chronic insomnia.
NCT00044629 Combined Behavioral/Pharmacological Therapy for Insomnia Completed National Institute of Mental Health (NIMH) Phase 2 2001-09-01 This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ambien Cr

Condition Name

Condition Name for Ambien Cr
Intervention Trials
Insomnia 9
Healthy 9
Sleep Initiation and Maintenance Disorders 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ambien Cr
Intervention Trials
Sleep Initiation and Maintenance Disorders 17
Depression 4
Parasomnias 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ambien Cr

Trials by Country

Trials by Country for Ambien Cr
Location Trials
United States 82
Canada 7
Germany 4
United Kingdom 4
Italy 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ambien Cr
Location Trials
California 8
Pennsylvania 8
New York 7
Massachusetts 6
Ohio 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ambien Cr

Clinical Trial Phase

Clinical Trial Phase for Ambien Cr
Clinical Trial Phase Trials
Phase 4 16
Phase 3 3
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ambien Cr
Clinical Trial Phase Trials
Completed 31
Recruiting 5
Active, not recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ambien Cr

Sponsor Name

Sponsor Name for Ambien Cr
Sponsor Trials
National Institute of Mental Health (NIMH) 6
Sanofi 5
Mclean Hospital 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ambien Cr
Sponsor Trials
Other 29
Industry 24
NIH 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Moodys
AstraZeneca
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.